Karin Bornfeldt

Karin Bornfeldt’s research is devoted to cardiovascular complications associated with diabetes. Her group uses a combination of human studies and research on mechanistic mouse models. Dr. Bornfeldt’s current work is focused on apolipoprotein C3 and remnants of triglyceride-rich lipoproteins in cardiovascular risk associated with diabetes.

She received her Ph.D. in Sweden and then did a postdoctoral fellowship at the University of Washington in the laboratory of Dr. Russell Ross. She is now Edwin L. Bierman Professor of Medicine, Division of Metabolism, Endocrinology, and Nutrition, and Professor of Laboratory Medicine and Pathology there. She serves as Director of the Diabetes Complications Program at the UW Medicine Diabetes Institute.

Dr. Bornfeldt is a Fellow of the American Heart Association (AHA), Associate Editor of Circulation Research, Guest Editor of Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB), and Associate Editor of the Journal of Lipid Research. Other honors include the AHA Russell Ross Memorial Lectureship in Vascular Biology (2013), the Edwin L. Bierman Lectureship, the American Diabetes Association (2014), the Journal of Lipid Research Lectureship (2019), the ATVB Special Recognition Award in Vascular Biology (2020), the David Rubenstein Lectureship award (2020) and the George Lyman Duff Memorial Lectureship Award, AHA (2021).